Cahill Represents Lead Arrangers in Resonetics’ $231 Million Incremental Credit Facilities

March 20, 2026

Cahill represented the lead arrangers in connection with an amendment to the First Lien Credit Agreement for Resonetics, LLC. The amendment raised (i) an incremental $220 million tranche of term loans and (ii) an incremental $10.6 million of revolving credit commitments.

Proceeds from the amendment were used to fund the acquisition of Resolution Medical MidCo, LLC and for general corporate purposes.

Resonetics is a medical technology company and global leader in advanced engineering, prototyping, product development, and micro manufacturing.